FEYAX
Price
$29.48
Change
-$0.02 (-0.07%)
Updated
Aug 15 closing price
Net Assets
4.94B
OGGCX
Price
$24.78
Change
-$0.03 (-0.12%)
Updated
Aug 15 closing price
Net Assets
6.27B
Interact to see
Advertisement

FEYAX vs OGGCX

Header iconFEYAX vs OGGCX Comparison
Open Charts FEYAX vs OGGCXBanner chart's image
Fidelity Advisor Asset Manager 85% A
Price$29.48
Change-$0.02 (-0.07%)
VolumeN/A
Net Assets4.94B
JPMorgan Investor Growth C
Price$24.78
Change-$0.03 (-0.12%)
VolumeN/A
Net Assets6.27B
FEYAX vs OGGCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FEYAX vs. OGGCX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEYAX is a Buy and OGGCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
OGGCX has more cash in the bank: 6.27B vs. FEYAX (4.94B). OGGCX pays higher dividends than FEYAX: OGGCX (1.99) vs FEYAX (1.07). FEYAX was incepted earlier than OGGCX: FEYAX (19 years) vs OGGCX (28 years). OGGCX (1.50) is less costly to investors than FEYAX (0.94). FEYAX is a more actively managed with annual turnover of: 16.00 vs. OGGCX (5.00). FEYAX has a lower initial minimum investment than OGGCX: FEYAX (0) vs OGGCX (500). FEYAX annual gain was more profitable for investors over the last year : 12.96 vs. OGGCX (12.01). FEYAX return over 5 years is better than : 49.56 vs. OGGCX (36.83).
FEYAXOGGCXFEYAX / OGGCX
Total Expense Ratio0.941.5063%
Annual Report Gross Expense Ratio0.941.5063%
Fund Existence19 years28 years-
Gain YTD12.98410.510124%
Front Load6%N/A-
Min. Initial Investment0500-
Min. Initial Investment IRAN/AN/A-
Net Assets4.94B6.27B79%
Annual Yield % from dividends1.071.9954%
Returns for 1 year12.9612.01108%
Returns for 3 years32.1224.25132%
Returns for 5 years49.5636.83135%
Returns for 10 years84.6746.16183%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRDGX83.83N/A
N/A
T. Rowe Price Dividend Growth
WFDRX33.31N/A
N/A
Allspring SMID Cap Growth Fund - Cl R6
ICTTX15.11N/A
N/A
ICON Health and Information Tech Inv
MLNCX25.72N/A
N/A
Morgan Stanley Instl Glbl Concntr C
GAHPX27.41N/A
N/A
Goldman Sachs Emerging Markets Eq P